Cargando…
Modification of avian pathogenic Escherichia coli χ7122 lipopolysaccharide increases accessibility to glycoconjugate antigens
BACKGROUND: Worldwide, an estimated 70.7 billion broilers were produced in 2020. With the reduction in use of prophylactic antibiotics as a result of consumer pressure and regulatory oversight alternative approaches, such as vaccination, are required to control bacterial infections. A potential way...
Autores principales: | Smith, Alexander A., Corona-Torres, Ricardo, Hewitt, Rachel E., Stevens, Mark P., Grant, Andrew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449299/ https://www.ncbi.nlm.nih.gov/pubmed/36071433 http://dx.doi.org/10.1186/s12934-022-01903-4 |
Ejemplares similares
-
Full Sequence and Comparative Analysis of the Plasmid pAPEC-1 of Avian Pathogenic E. coli χ7122 (O78∶K80∶H9)
por: Mellata, Melha, et al.
Publicado: (2009) -
Development of an automated platform for the optimal production of glycoconjugate vaccines expressed in Escherichia coli
por: Samaras, Jasmin J., et al.
Publicado: (2021) -
Genome Sequence of Salmonella Phage χ
por: Hendrix, Roger W., et al.
Publicado: (2015) -
Sectional Anatomy Quiz–IΧ
por: Azaan Khan, Muhammad, et al.
Publicado: (2023) -
Carriers and Antigens: New Developments in Glycoconjugate Vaccines
por: van der Put, Robert M.F., et al.
Publicado: (2023)